Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Phathom Pharmaceuticals (NASDAQ:PHAT) Gains as Gastrointestinal Drug Stock Moves Higher

• Phathom Pharmaceuticals Inc. (PHAT) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 6.31%.

Nitish Kishor | 06 July 2026

Polaryx Therapeutics (NASDAQ:PLYX) Rises as Rare-Disease Biotech Stocks Gain Attention

• Polaryx Therapeutics Inc. (PLYX) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 8.91%.

Nitish Kishor | 06 July 2026

Precigen (NASDAQ:PGEN) Gains Attention as Biotech Investors Track Active Trading

• Precigen Inc. (PGEN) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 7.43%.

Nitish Kishor | 06 July 2026

Rivian Automotive (NASDAQ:RIVN) Rallies as EV Stock Returns to Investor Watchlists

• Rivian Automotive Inc. Cl A (RIVN) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 8.44%.

Nitish Kishor | 06 July 2026

Orthofix Medical (NASDAQ:OFIX) Rises as Medical Device Stock Attracts Fresh Interest

• Orthofix Medical Inc. (OFIX) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 6.31%.

Nitish Kishor | 06 July 2026

Palvella Therapeutics (NASDAQ:PVLA) Climbs as Rare-Disease Biotech Stock Draws Attention

• Palvella Therapeutics Inc. (PVLA) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 6.15%.

Nitish Kishor | 06 July 2026

Parabilis Medicines (NASDAQ:PBLS) Moves Higher as Biotech Investors Track Strong Session

• Parabilis Medicines Inc. (PBLS) featured on the US stock movers gainers list dated July 2, 2026, with the latest market data showing a move of about 6.56%.

Nitish Kishor | 06 July 2026

Gyre Therapeutics (NASDAQ: GYRE) Deep Dive: What NMPA NDA Acceptance for F351 Means for Liver Fibrosis Treatment

NDA acceptance by the NMPA initiates the formal review clock for the submission and signals that regulators deemed the application package sufficiently complete for substantive review. This procedural milestone is an important de-risking event for the drug candidate's timeline, distinguishing companies with accepted applications …

Nitish Kishor | 05 July 2026

Teekay Tankers (NYSE: TNK) Stock Surges on Maersk EBITDA Guidance Raise and Strait of Hormuz Optimism

The evolving situation in the Strait of Hormuz remains a key catalyst for tanker investors specifically. Uncertainty around potential transit fees and Iran's long-term control ambitions over this critical maritime chokepoint could structurally reshape tanker trade routes and demand patterns in ways that favor …

Nitish Kishor | 05 July 2026

Small-Cap Russell Index Dynamics 2026: Winners and Losers From Reconstitution

The reconstitution mechanics also affected DLocal (NASDAQ: DLO) through Russell growth benchmark inclusion, a development that compounded the positive impact of a separate UBS analyst upgrade on the emerging markets payments company. REalloys (NASDAQ: REAI) experienced Russell 2000 addition at essentially the same time …

Nitish Kishor | 05 July 2026
Support

Hi! How can we help you today?

Loading…